Navigating the controversies and complexities of implementing Lecanemab in the Veterans Affairs Health System

Abstract: The article focuses on the evolving landscape of Alzheimer's disease (AD) diagnosis and treatment, particularly the implementation of anti-amyloid therapies like …

83. Supporting the safety of anti-amyloid monoclonal antibody therapy for early Alzheimer's disease in United States Veterans

Abstract: Introduction Aging United States Military Veterans are at an increased risk of developing dementia compared to the general population due to both military and …

Implementation of lecanemab for Alzheimer's disease within the Veterans Health Administration: Facilitators and barriers

Abstract: Background: Several amyloid targeting therapies have been approved for Alzheimer's disease (AD), including lecanemab (Leqembi). However, real-world implementation of …